MedTrace Logo

Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer

NCT01187602 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2014-12-05

No results posted yet for this study

Summary

The purpose of this study is to create new tests to identify biomarkers for ovarian cancer so that a screening test can be developed. For patients who have a diagnosis of ovarian Cancer, researchers will use blood samples before and after treatment to see if disease status can be determined by measuring the amount of biomarker.

Conditions

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • Susan Modesitt, MD · University of Virginia

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01187602 on ClinicalTrials.gov